Among the 32 tumors of the discovery set, 23 (72 %) of CD15/FUT4-positive tumors were classified as low or high and had a higher recurrence than other tumor-related immune antigen i.e., CD68, CD73 (Fig. 1b, c and Additional file 2: Figure S2A). Here, NT5E is linked to neoplasm.